The Biotech Resurgence
This current wave of biotech investment aligns with a broader investor thesis that views the sector as a ripe area for growth.
All stories
Business narratives worth tracking.
Filter by category or scan the full story archive.
Artificial Intelligence
Cannabis
Crypto
Food Tech
Longevity
Biotech
Mining
Psychedelics
Sustainability
Technology
Venture Capital
A New Dawn for Postpartum Depression Treatment
Sage Therapeutics and Biogen's new drug is the first oral medication designed specifically to treat postpartum depression.
Nanomedicine Is The Future of Safe and Effective Drug Therapies
Nanomedicine startups like Taiwan Liposome Company are using proprietary lipid delivery technology to treat diseases at the cellular level.
AstraZeneca Partners with AI Startup in $247M Oncology AI Venture
AI continues to be essential for drug development research as total investments in AI-enabled drug discovery reaches $5.2B since 2021.
Sanofi’s $140M Bet on Parisian Startup’s AI Platform for Drug Discovery
Sanofi continues to push the boundaries of drug discovery by acquiring another AI startup.
AI Health Platform Used to Extend Human Healthspan
Hong Kong-based Insilico Medicine has joined forces with New Zealand's SRW Laboratories to harness the power of AI in longevity development.
How AI Collaboration in Sanofi is Reshaping Pharma’s Investment Landscape
Sanofi invests $10 million in BioMap to bolster AI-powered drug research and enhance medical breakthroughs.
AI-Driven Biotech Genesis Therapeutics’ $200M Signals Sector Maturity
Genesis Therapeutics' $200 million funding highlights the biotech industry's growing confidence in AI's transformative potential for drug development.